Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (320)
  • Autophagy
    (158)
  • CDK
    (138)
  • PROTACs
    (120)
  • 5-HT Receptor
    (111)
  • Antibacterial
    (109)
  • Epigenetic Reader Domain
    (106)
  • PI3K
    (103)
  • Drug-Linker Conjugates for ADC
    (101)
  • Others
    (6252)
Filter
Search Result
Results for "

potent

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12441
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    639
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    54
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    41
    TargetMol | Dye_Reagents
  • PROTAC Products
    323
    TargetMol | PROTAC
  • Natural Products
    768
    TargetMol | Natural_Products
  • Recombinant Protein
    116
    TargetMol | Recombinant_Protein
  • Isotope Products
    81
    TargetMol | Isotope_Products
  • Disease Modeling
    15
    TargetMol | Disease_Modeling_Products
  • Cell Research
    21
    TargetMol | Inhibitors_Agonists
GLPG2938
1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea
T91992130996-00-6
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) is a potent and selective antagonist of S1P2.
  • Inquiry Price
Size
QTY
Emodin 6-O-β-D-glucoside
Glucoemodin
TN677434298-85-6
Emodin 6-O-β-D-glucoside (Glucoemodin) can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock. Emodin 6-O-beta-D-glucoside has anti-inflammatory activities and also may have significant therapeutic benefits against diabetic complications and atherosclerosis.
  • Inquiry Price
Size
QTY
Bradykinin potentiator B
T7650530892-86-5
Bradykinin Potentiator B (also known as Bradykinin Potentiating Peptide B), derived from the venom of Agkistrodon halys blomhoffi, serves as a potent ACE inhibitor. It effectively inhibits the activity of bradykinin inhibitory peptidase [1].
  • Inquiry Price
Size
QTY
Bradykinin potentiator C
T7650730953-20-9
Bradykinin Potentiator C, a potent inhibitor of angiotensin-converting enzyme (ACE) with an inhibitory concentration (IC 50) of 7.1 μM for rabbit lung ACE, is regarded as a prototype for functional peptides [1].
  • Inquiry Price
Size
QTY
KCC2 potentiators-1
T2034143058906-46-7
Compound 2, known as KCC2 potentiators-1, acts as an enhancer of the potassium chloride cotransporter-2 (KCC2). It holds potential for applications in studies related to neurological disorders.
  • Inquiry Price
Size
QTY
aminopotentidine
T22566140873-26-3
H2 antagonist
  • Inquiry Price
6-8 weeks
Size
QTY
Bradykinin potentiator-5
BPP-5a , BPP5a , BPP 5a
T2517330505-63-6
Bradykinin potentiator-5 is a peptide inflammatory mediator, causes blood vessels to dilate (enlarge), and therefore causes blood pressure to fall.
  • Inquiry Price
Size
QTY
OV-potentiator-28
OV potentiator 28
T28276
OV-potentiator-28 is a potentiator of cancer virotherapy. OV-potentiator-28 significantly enhances virus replication-associated luciferase expression, specifically in tumors.
  • Inquiry Price
Size
QTY
nmda receptor potentiator-1
T63003486427-18-3
NMDA receptor potentiator-1 (Compound 1368) is a subunit-selective NMDA receptor enhancer with IC50 values of 4 μM for NR2C and 5 μM for NR2D expression.
  • Inquiry Price
6-8 weeks
Size
QTY
Potentillanoside A
T814181309589-79-4
Potentillanoside A is a natural hepatoprotective compound [1].
  • Inquiry Price
Size
QTY
Ruxolitinib
INCB018424, (R)-Ruxolitinib
T1829941678-49-5
Ruxolitinib (INCB018424) is a JAK1 2 inhibitor (IC50=3.3 2.8 nM) that is potent and selective. Rixolitinib exhibits antitumor activity and induces autophagy and apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Liproxstatin-1
T2376950455-15-9
Liproxstatin-1 is a potent and selective inhibitor of ferroptosis (IC50=22 nM). Liproxstatin-1 protects cells from ferroptosis induced by ferroptosis inducers (e.g., Erastin, RSL3).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
RMC-6236
RMC6236
T746982765081-21-6
RMC-6236 is an orally effective and novel triple complex RAS (ON) MULTI inhibitor, which is a potent non covalent inhibitor of multiple RAS variants in GTP binding state. RMC-6236 has anti-tumor activity and can be used in research related to RAS driven tumors. With rich experience in compound synthesis, we can provide fast customized synthesis services for this product according to your research needs.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
MRTX1133
T93032621928-55-8In house
MRTX1133 is a KRAS G12D inhibitor (KD=0.2 pM) that is potent, selective, and non-covalent. MRTX1133 exhibits inhibitory activity against KRAS G12D-mutated tumors, but not against KRAS wild-type tumors.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Edaravone
MCI-186
T040789-25-8
Edaravone (MCI-186) is a potent new free radical scavenger used for the therapy of patients with acute brain infarction.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
A2B receptor antagonist 1
T10058531506-36-2In house
A2B receptor antagonist 1 (EXAMPLE 9B) is a potent A2B adenosine receptor antagonist.
  • Inquiry Price
8-10 weeks
Size
QTY
TargetMol | Inhibitor Hot
CL 316243
T10830138908-40-4In house
CL316243 is a highly potent selective agonist of β3-adrenoceptor, with a EC50 of 3 nM. CL316243 is an effective stimulant of adipocyte lipolysis and increases brown adipose tissue thermogenesis and metabolic rate. CL316243 has the potential for the treatment obesity, diabetes and urge urinary incontinence.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Hot
cmf019
T108431586787-08-7In house
CMF019 is a potent agonist of the Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ (pKis: 8.58, 8.49, and 8.71 for the human, rat, and mouse).
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Hot
Dxd
UNII-OQM5SD32BQ, OQM5SD32BQ, Exatecan derivative for ADC
T11249L1599440-33-1
Dxd (OQM5SD32BQ) is a potent inhibitor of DNA topoisomerase I with an IC50 of 0.31 μM. It is used as a conjugated drug of HER2-targeting ADC.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
gnf4877
T114472041073-22-5In house
GNF4877 is a potent inhibitor of DYRK1A and GSK3β (IC50s: 6 nM and 16 nM, respectively), resulting in the blockade of nuclear export of nuclear factor of activated T-cells (NFATc) and increased β-cell proliferation.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
O-Propargyl-Puromycin
O-Propargylpuromycin, OP-puro
T122841416561-90-4In house
O-Propargyl-Puromycin (OP-puro) is a potent protein synthesis inhibitor, a puromycin acetylene analog.
  • Inquiry Price
10-14 weeks
Size
QTY
TargetMol | Inhibitor Hot
vipivotide tetraxetan
PSMA-617
T125731702967-37-0
Vipivotide tetraxetan (PSMA-617) is a highly potent inhibitor of prostate-specific membrane antigen (PSMA) with a Ki of 0.37 nM.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
5-HT2 antagonist 1
T12597191592-09-3In house
5-HT2 antagonist 1 is a potent 5-HT2 receptor antagonist with weak α1 adrenoceptor blocking activity.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Hot
TPN171
T131931229018-87-4In house
TPN171 is potent PDE5 inhibitor with subnanomolar potency for PDE5 and good selectivity over PDE6, which has the potential for the treatment of pulmonary arterial hypertension (PAH). TPN171 was proven to exert a longer lasting effect than sildenafil in animal models, providing a foundation for a once-daily oral administration for its clinical use.
  • Inquiry Price
8-10weeks
Size
QTY
TargetMol | Inhibitor Hot